In the context of cancer, acetylation of pyruvate dehydrogenase complex component X (PDHX) has been demonstrated to disrupt the assembly of PDC, resulting in elevated lactate production and subsequent lactylation-mediated gene expression, thereby facilitating tumor progression. Here, PDHX is linked to neoplasm.